ACE |
angiotensin-converting enzyme |
ACE2 |
angiotensin-converting enzyme 2 |
ACEI |
angiotensin-converting enzyme inhibitors |
AChE |
acetylcholinesterase |
AD |
Alzheimer’s disease |
ALS |
amyotrophic lateral sclerosis |
Ang II |
angiotensin II |
Ang-(1-7) |
angiotensin-(1-7) |
ApoE |
apolipoprotein E |
ARBs |
Angiotensin II type 1 (AT1) receptor blockers |
BBB |
blood-brain barrier |
BDNF |
brain-derived neurotrophic factor |
ChAT |
choline acetyltransferase |
CI |
confidence interval |
CNS |
central nervous system |
COPD |
chronic obstructive pulmonary disease |
COVID-19 |
coronavirus disease 2019 |
CSF |
cerebrospinal fluid |
GM-CSF |
granulocyte macrophage-colony stimulating factor |
HCV |
hepatitis C virus |
HiPSCs |
human-induced pluripotent stem cells |
IFN |
interferon |
IL-1β |
interleukin-1β |
IL-2 |
interleukin-2 |
IL-6 |
interleukin-6 |
IL-10 |
interleukin-10 |
IP-10 |
interferon-γ-inducible protein 10 |
HIV |
human immunodeficiency virus |
HSV |
herpes simplex virus |
mACE2 |
membrane-bound ACE2 |
MCP-1 |
monocyte chemoattractant protein-1 |
MMSE |
Mini-Mental State Examination |
NPI |
Neuropsychiatric Inventory |
PD |
Parkinson’s disease |
PET |
positron emission tomography |
NLRP3 |
NLR family pyrin domain-containing protein 3 |
OR |
odds ratio |
ORF3a |
open reading frame 3a |
RCD |
rapid cognitive decline |
ROS |
reactive oxygen species |
sACE2 |
soluble ACE2 |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
TNF-α |
tumor necrosis factor α |